Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

JB CHEMICALS & PHARMACEUTICALS LTD.

NSE : JBCHEPHARMBSE : 506943ISIN CODE : INE572A01036Industry : Pharmaceuticals & DrugsHouse : Private

BSE2208.55-1.3 (-0.06 %)

PREV CLOSE ( ) 2209.85

OPEN PRICE ( ) 2208.30

BID PRICE (QTY) 2205.00 (263)

OFFER PRICE (QTY) 2208.55 (166)

VOLUME 2781

TODAY'S LOW / HIGH ( )2206.05 2250.00

52 WK LOW / HIGH ( )1603.05 2284.95

NSE2212.702.5 (+0.11 %)

PREV CLOSE( ) 2210.20

OPEN PRICE ( ) 2209.90

BID PRICE (QTY) 2212.00 (5)

OFFER PRICE (QTY) 2212.80 (27)

VOLUME 238644

TODAY'S LOW / HIGH( ) 2190.10 2250.30

52 WK LOW / HIGH ( )1603.5 2285.3

Quarters

Select year

( in Million)

Particulars

Mar 2026

Dec 2025

Sep 2025

Jun 2025

Audited / UnAudited

UnAudited

Net Sales

9042.3

10647.2

10849

10939.4

Total Expenditure

7031

7689

7753

7930.7

PBIDT (Excl OI)

2011.3

2958.2

3096

3008.7

Other Income

119.8

182.8

153.4

145.5

Operating Profit

2131.1

3141

3249.4

3154.2

Interest

12.3

18.8

13.5

11.1

Exceptional Items

-271.8

PBDT

1847

3122.2

3235.9

3143.1

Depreciation

500.1

453.5

444.4

427

Profit Before Tax

1346.9

2668.7

2791.5

2716.1

Tax

333.2

689.8

713.3

692.3

Provisions and contingencies

Profit After Tax

1013.7

1978.9

2078.2

2023.8

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

1013.7

1978.9

2078.2

2023.8

Minority Interest

Shares of Associates

Other related items

Misc. Expenses Written off

Consolidated Net Profit

1013.7

1978.9

2078.2

2023.8

Equity Capital

160.6

156.7

156.6

156.1

Face Value (IN RS)

Reserves

Calculated EPS

6.31

12.62

13.27

12.96

Calculated EPS (Annualised)

25.24

50.51

53.08

51.85

No of Public Share Holdings

82200814

82169437

82114720

81577405

% of Public Share Holdings

51.2

52.45

52.44

52.27

PBIDTM% (Excl OI)

22.24

27.78

28.53

27.50

PBIDTM%

23.56

29.50

29.95

28.83

PBDTM%

20.42

29.32

29.82

28.73

PBTM%

14.89

25.06

25.73

24.82

PATM%

11.21

18.58

19.15

18.50

Notes

Risk Disclosures on Derivatives

Quarterly Results

JB CHEMICALS & PHARMACEUTICALS LTD.